{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:48:23Z","timestamp":1775756903446,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10238-012-0215-4","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T19:17:53Z","timestamp":1349723873000},"page":"107-113","source":"Crossref","is-referenced-by-count":36,"title":["Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer"],"prefix":"10.1007","volume":"14","author":[{"given":"Anna","family":"Krze\u015blak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Forma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Szymczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Smolarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Romanowicz-Makowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"R\u00f3\u017ca\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Bry\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,6]]},"reference":[{"key":"215_CR1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00018-002-8454-2","volume":"59","author":"P Coyle","year":"2002","unstructured":"Coyle P, Philcox JC, Carey LC, Rofe AM (2002) Metallothionein: the multipurpose protein. Cell Mol Sci 59:627\u2013647","journal-title":"Cell Mol Sci"},{"key":"215_CR2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3748\/wjg.v13.i7.993","volume":"13","author":"N Thirumoorthy","year":"2007","unstructured":"Thirumoorthy N, Manisenthil Kumar KT, Shyam Sunder A, Panayappan L, Chatterjee M (2007) Metallothionei: an overview. World J Gastroenerol 13:993\u2013996","journal-title":"World J Gastroenerol"},{"key":"215_CR3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7819-9-54","volume":"9","author":"N Thirumoorthy","year":"2011","unstructured":"Thirumoorthy N, Shyam Sunder A, Manisenthil Kumar K, Senthil Kumar M, Ganesh G, Chatterjee M (2011) A review of metallothionein isoforms and their role in pathophysiology. World J Surg Oncol 9:54. doi: 10.1186\/1477-7819-9-54","journal-title":"World J Surg Oncol"},{"key":"215_CR4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10534-010-9351-z","volume":"23","author":"I Saboli\u0107","year":"2010","unstructured":"Saboli\u0107 I, Breljak D, Skarica M, Herak-Kramberger CM (2010) Role of metallothionein in cadmium traffic and toxicity in kidneys and other mammalian organs. Biometals 23:897\u2013926","journal-title":"Biometals"},{"key":"215_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.proghi.2008.10.001","volume":"44","author":"M\u00d8 Pedersen","year":"2009","unstructured":"Pedersen M\u00d8, Larsen A, Stoltenberg M, Penkowa M (2009) The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem 44:29\u201364","journal-title":"Prog Histochem Cytochem"},{"key":"215_CR6","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00775-011-0823-6","volume":"16","author":"M Namdarghanbari","year":"2011","unstructured":"Namdarghanbari M, Wobig W, Krezoski S, Tabatabai NM, Petering DH (2011) Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy. J Biol Inorg Chem 16:1087\u20131101","journal-title":"J Biol Inorg Chem"},{"key":"215_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mrfmmm.2003.07.013","volume":"533","author":"MG Cherian","year":"2003","unstructured":"Cherian MG, Jayasurya A, Bay BH (2003) Metallothionein in human tumors and potential roles in carcinogenesis. Mutat Res 533:201\u2013209","journal-title":"Mutat Res"},{"key":"215_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mrfmmm.2003.07.014","volume":"533","author":"F Haq","year":"2003","unstructured":"Haq F, Mahoiney M, Kropatnicki J (2003) Signaling events for metallothionein induction. Mutat Res 533:211\u2013226","journal-title":"Mutat Res"},{"key":"215_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2559.2004.01922.x","volume":"45","author":"SE Theocharis","year":"2004","unstructured":"Theocharis SE, Margeli AP, Kilijanienko JT, Kouraklis GP (2004) Metallothionein expression in human neoplasia. Histopthology 45:103\u2013118","journal-title":"Histopthology"},{"key":"215_CR10","first-page":"3","volume":"55","author":"P Dziegiel","year":"2004","unstructured":"Dziegiel P (2004) Expression of metallothionein in human cells. Pol J Pathol 55:3\u201312","journal-title":"Pol J Pathol"},{"key":"215_CR11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02893459","volume":"10","author":"R Jin","year":"2004","unstructured":"Jin R, Huang J, Tan P, Bay B (2004) Clinicopathological significance of metallothioneins in breast cancer. Pathol Oncol Res 10:74\u201379","journal-title":"Pathol Oncol Res"},{"key":"215_CR12","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1177\/153537020623100910","volume":"231","author":"BH Bay","year":"2006","unstructured":"Bay BH, Jin R, Huang J, Tan PH (2006) Metallothionein as a prognostic biomarker in breast cancer. Exp Biol Med (Maywood) 231:1516\u20131521","journal-title":"Exp Biol Med (Maywood)"},{"key":"215_CR13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00439-006-0238-6","volume":"120","author":"K Kita","year":"2006","unstructured":"Kita K, Miura M, Yoshida M et al (2006) Potential effect on cellular response to cadmium of a single-nucleotide A\u2192G polymorphism in the promoter of the human gene for metallothionein IIA. Hum Genet 120:553\u2013560","journal-title":"Hum Genet"},{"key":"215_CR14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10522-005-4907-y","volume":"6","author":"R Giacconi","year":"2005","unstructured":"Giacconi R, Cipriano C, Muti E et al (2005) Novel \u2212209A\/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 6:407\u2013413","journal-title":"Biogerontology"},{"key":"215_CR15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2119\/2007-00045.Giacconi","volume":"13","author":"R Giacconi","year":"2007","unstructured":"Giacconi R, Muti E, Malavolta M et al (2007) The +838 C\/G MT2A polymorphism, metals, and the inflammatory\/immune response in carotid artery stenosis in elderly people. Mol Med 13:388\u2013395","journal-title":"Mol Med"},{"key":"215_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11033-009-9586-3","volume":"37","author":"Z Kayaalti","year":"2010","unstructured":"Kayaalti Z, S\u00f6ylemezoglu T (2010) The polymorphism of core promoter region om metallothionein 2A-metal binding protein in Turkish population. Mol Biol Rep 37:185\u2013190","journal-title":"Mol Biol Rep"},{"key":"215_CR17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/15287394.2010.485067","volume":"73","author":"JA McElroy","year":"2010","unstructured":"McElroy JA, Bryda EC, McKay SD, Schnabel RD, Taylor JF (2010) Genetic variation at a metallothionein 2A promoter single-nucleotide polymorphism in white and black females in Midwestern United States. J Toxicol Environ Health A 73:1283\u20131287","journal-title":"J Toxicol Environ Health A"},{"key":"215_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2011.06.023","volume":"256","author":"Z Kayaalt\u0131","year":"2011","unstructured":"Kayaalt\u0131 Z, Aliyev V, S\u00f6ylemezo\u011flu T (2011) The potential effect of metallothionein 2A\u20135A\/G single nucleotide polymorphism on blood cadmium, lead, zinc and copper levels. Toxicol Appl Pharmacol 256:1\u20137","journal-title":"Toxicol Appl Pharmacol"},{"key":"215_CR19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.taap.2010.03.007","volume":"245","author":"Z Kayaalti","year":"2011","unstructured":"Kayaalti Z, Mergen G, S\u00f6ylemezo\u011flu T (2011) Effect of metallothionein core promoter region polymorphism on cadmium, zinc and copper levels in autopsy kidney tissues from a Turkish population. Toxicol Appl Pharmacol 245:252\u2013255","journal-title":"Toxicol Appl Pharmacol"},{"key":"215_CR20","doi-asserted-by":"crossref","unstructured":"Tekin D, Kayaalt\u0131 Z, S\u00f6ylemezo\u011flu T (2012) The effects of metallothionein 2A polymorphism on lead metabolism: are pregnant women with a heterozygote genotype for metallothionein 2A polymorphism and their newborns at risk of having higher blood lead levels. Int Arch Occup Environ Health 85:631\u2013637","DOI":"10.1007\/s00420-011-0711-y"},{"key":"215_CR21","doi-asserted-by":"crossref","first-page":"E987","DOI":"10.1152\/ajpendo.90234.2008","volume":"294","author":"L Yang","year":"2008","unstructured":"Yang L, Li H, Yu T et al (2008) Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications. Am J Physiol Endocrinol Metab 294:E987\u2013E992","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"215_CR22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/carcin\/23.1.81","volume":"23","author":"R Jin","year":"2002","unstructured":"Jin R, Chow VT, Tan PH, Dheen ST, Duan W, Bay BH (2002) Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 23:81\u201386","journal-title":"Carcinogenesis"},{"key":"215_CR23","first-page":"199","volume":"4","author":"A Abdel-Mageed","year":"1997","unstructured":"Abdel-Mageed A, Agrawal KC (1997) Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther 4:199\u2013207","journal-title":"Cancer Gene Ther"},{"key":"215_CR24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2008.10.038","volume":"276","author":"D Lim","year":"2009","unstructured":"Lim D, Jocelyn KM, Yip GW, Bay BH (2009) Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells. Cancer Lett 276:109\u2013117","journal-title":"Cancer Lett"},{"key":"215_CR25","doi-asserted-by":"crossref","first-page":"38957","DOI":"10.1074\/jbc.C000593200","volume":"275","author":"L Cai","year":"2000","unstructured":"Cai L, Klein JB, Kang YJ (2000) Metallothionein inhibits peroxynitriteinduced DNA and lipoprotein damage. J Biol Chem 275:38957\u201338960","journal-title":"J Biol Chem"},{"key":"215_CR26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/toxsci\/kfg095","volume":"73","author":"R Shimoda","year":"2003","unstructured":"Shimoda R, Achanzar WE, Qu W et al (2003) Metallothionein is a potential negative regulator of apoptosis. Toxicol Sci 73:294\u2013300","journal-title":"Toxicol Sci"},{"key":"215_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.febslet.2010.12.030","volume":"585","author":"HG Kim","year":"2011","unstructured":"Kim HG, Kim JY, Han EH et al (2011) Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells. FEBS Lett 585:421\u2013428","journal-title":"FEBS Lett"},{"key":"215_CR28","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/ijc.25761","volume":"129","author":"P Seibold","year":"2011","unstructured":"Seibold P, Hein R, Schmezer P et al (2011) Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk. Int J Cancer 129:1467\u20131476","journal-title":"Int J Cancer"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-012-0215-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T01:08:23Z","timestamp":1498007303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-012-0215-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["215"],"URL":"https:\/\/doi.org\/10.1007\/s10238-012-0215-4","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,6]]}}}